Partners

Target-In recognizes that strategic partners and joint ventures play an important role in a company's growth and success. To date, Target-In has signed two licensing agreements with an Indian pharmaceutical company, Century Pharmaceutical, for the development of allergic disorders and asthma therapies. Target-In will co-develop its treatment with Century Pharmaceuticals. Additional apofusion candidates have been out-licensed to strategic partners and include a US-based company in Palo Alto, California, which is developing an anti-leukemia application.
Target-In is currently expanding its operations worldwide and welcomes interested biotechnology and pharmaceutical partnerships and alliances. For more information, please contact us:

Target-In Ltd.
14 Shenkar Street, P.O.B. 3917
Petach Tikva, Israel 49513

Tel: +972 3-925.6760
Fax: +972 3-924.1346
Email: info@target-in.com